Sign In
Buy BAYRY
$9.92
+0.0400 (+0.405%)
At Close: Jun 03, 2026
Bayer to acquire Vividion Therapeutics in a $2 billion deal
01:35am, Thursday, 05'th Aug 2021
Bayer to acquire Vividion Therapeutics in a $2 billion deal
Bayer posts additional $4.5 billion provision for Roundup litigation
09:14am, Thursday, 29'th Jul 2021
Germany's Bayer said on Thursday that it would post an additional provision of $4.5 billion related to litigation of its Roundup weedkiller.
Bayer says to appeal U.S. court ruling on PCBs if necessary
05:19am, Wednesday, 28'th Jul 2021
German chemicals maker Bayer said on Wednesday it may appeal an order in a U.S. legal case to pay $185 million to four staff members of a school in the state of Washington over exposure to polychlorin
Bayer Aktiengesellschaft (BAYRY) Upgraded to Buy: Here's What You Should Know
01:44pm, Thursday, 22'nd Jul 2021
Bayer Aktiengesellschaft (BAYRY) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Bayer's (BAYRY) Parkinson's Disease Therapy Gets Fast Track Tag
12:23pm, Tuesday, 20'th Jul 2021
The FDA grants a Fast Track status to Bayer's (BAYRY) DA01 cell therapy which is being developed for the treatment of Parkinson's disease.
Bayer's Kerendia Scores Long-Awaited Kidney & Heart Disease Nod For Type 2 Diabetes
07:11am, Monday, 12'th Jul 2021
The FDA on Friday approved Bayer AG's (OTC: BAYRY) chronic kidney disease (CKD) drug Kerendia (finerenone), the first and only nonsteroidal mineralocorticoid receptor antagonist. Finerenone is indi
3 Top Biotech Stocks to Buy in July
06:43am, Sunday, 11'th Jul 2021
Now's the time to get into these companies while their valuation is still favorable.
3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season (Revised)
01:31am, Friday, 09'th Jul 2021
AstraZeneca (AZN), AbbVie (ABBV) and Bayer (BAYRY) are three large drug sector companies worth buying now.
3 Big Drugmakers to Buy Ahead of the Q2 Earnings Season
10:31am, Tuesday, 06'th Jul 2021
AstraZeneca (AZN), AbbVie (ABBV) and Bayer (BAYRY) are three large drug sector companies worth buying now.
3 Big Drugmakers Likely to be in Focus in Second Half of 2021
10:31am, Thursday, 01'st Jul 2021
Eli Lilly (LLY), Pfizer (PFE) and Bayer (BAYRY) are three large drug sector companies worth buying and holding for the next few months and beyond.
J&J (JNJ)/Bayer Seek Nod for Xarelto for Blood Clots in Kids
11:17am, Thursday, 24'th Jun 2021
J&J (JNJ) and its partner Bayer seek approval of Xarelto as a treatment and prevention for venous thromboembolism in pediatric patients.
Bayer's Cell, Gene Therapies for Parkinson's Disease Enters Human Trials
02:16pm, Tuesday, 08'th Jun 2021
Bayer AG's (OTC: BAYRY) Parkinson's disease stem cell therapy has officially landed in the clinic, while another treatment for the neurodegenerative movement disorder is recruiting patients. Bayer's
Bayer to Advance Two First-of-its-Kind Investigational Cell and Gene Therapies for Parkinson's Disease
07:05am, Tuesday, 08'th Jun 2021
BERLIN--(BUSINESS WIRE)--Bayer AG announced today that BlueRock Therapeutics (BlueRock), a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, successfully administered t
Bayer Buys Two Biotech Firms to Beef Up Radiopharmaceuticals
03:25pm, Thursday, 03'rd Jun 2021
Bayer AG (OTC: BAYRY) will acquire two small biotech companies in a deal that adds an experimental prostate cancer medicine to the German drugmaker's pipeline. Bayer will pay an undisclosed sum for
Bayer Mulls Ending US Retail Sales Of Weedkiller Glyphosate: Reuters
12:59pm, Thursday, 27'th May 2021
A U.S. judge rejected Bayer AG's (OTC: BAYRY) plan to try and limit the cost of future class action claims that its Roundup weedkiller causes cancer, saying that parts of the plan were “clearly un
